Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
108 studies found for:    Open Studies | "Thrombocytopenia"
Show Display Options
Rank Status Study
21 Recruiting Prevention of Thrombocytopenia in Glioblastoma Patients
Conditions: Thrombocytopenia;   Glioblastoma
Intervention: Drug: Romiplostim
22 Not yet recruiting Rituximab and Dexamethasone Followed by Mycophenolate Mofetil or Placebo in Patients With Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Rituximab;   Drug: Dexamethasone;   Drug: Mycophenolate mofetil;   Drug: Placebo
23 Recruiting Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Interventions: Drug: Romiplostim;   Drug: Placebo
24 Not yet recruiting This Clinical Study is to Test Efficacy and Safety of BT595 in Chronic Primary Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia
Intervention: Biological: BT595
25 Recruiting Immune Thrombocytopenia in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Other: No intervention
26 Not yet recruiting Prospective Study of Patients With Thrombocytopenia Following HSCT
Conditions: Thrombocytopenia;   Hematologic Diseases
Interventions: Drug: decitabine;   Drug: rhTPO
27 Recruiting Evaluating the Pharmacokinetics and Pharmacodynamics of Romiplostim in Patients With Immune Thrombocytopenia (ITP)
Condition: Immune Thrombocytopenia (ITP)
Intervention: Drug: Romiplostim
28 Recruiting A Study of Eltrombopag in Patients With CMML and Thrombocytopenia
Conditions: CMML;   Thrombocytopenia
Intervention: Drug: eltrombopag
29 Recruiting Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Alloimmune Platelet Refractoriness
Intervention: Drug: Eculizumab
30 Recruiting Recombinant Human Thrombopoietin (rhTPO) in Management of Immune Thrombocytopenia (ITP) in Pregnancy
Conditions: Immune Thrombocytopenia;   Pregnancy
Intervention: Drug: rhTPO
31 Recruiting Immunogenetics of Heparin-Induced Thrombocytopenia: Aim 2
Condition: Heparin-induced Thrombocytopenia
Intervention: Procedure: Blood Draw
32 Not yet recruiting Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia
Conditions: Hematologic Malignancies;   Hypoproliferative Thrombocytopenia
Interventions: Device: Mirasol platelets (MIR PLTs);   Device: Reference platelets (REF PLTs)
33 Recruiting RP% Measurement by FCM as a Diagnostic Test for ITP
Condition: Immune Thrombocytopenia
Intervention: Other: RP% Measurement by FCM as a Diagnostic Test for ITP
34 Recruiting Safety and Efficacy Study of Lusutrombopag for Thrombocytopenia in Patients With Chronic Liver Disease Undergoing Elective Invasive Procedures
Conditions: Chronic Liver Disease;   Thrombocytopenia
Interventions: Drug: Lusutrombopag;   Drug: Placebo
35 Recruiting The International ITP Registry
Condition: Thrombocytopenia
Intervention:
36 Not yet recruiting The Effect of Recombinant Human Thrombopoietin on Septic Shock With Thrombocytopenia.
Conditions: Sepsis;   Thrombocytopenia
Interventions: Drug: rhTPO;   Drug: Placebo
37 Not yet recruiting Treatment of ITP With Rituximab and / or Accutane
Condition: Immune Thrombocytopenia
Interventions: Drug: Rituximab plus methylprednisolone;   Drug: methylprednisolone
38 Not yet recruiting Efficacy and Safety of DAPSone as a Second-line Option in Adult Immune Thrombocytopenia
Conditions: Adult Immune Thrombocytopenia (ITP);   Dapsone
Interventions: Drug: Dapsone (Disulone®);   Drug: Prednisone (Cortancyl®) alone followed by monitoring and "standard of care";   Drug: Prednisone (Cortancyl®)
39 Recruiting The ITP-RITUX Cohort: Rituximab in Immune ThrombocytoPenia.
Conditions: Purpura, Thrombocytopenic, Idiopathic;   Autoimmune Thrombocytopenia
Intervention:
40 Recruiting Eltrombopag for the Treatment of Thrombocytopenia Due to Low- and Intermediate Risk Myelodysplastic Syndromes
Conditions: Myelodysplastic Syndromes;   Thrombocytopenia
Interventions: Drug: Eltrombopag/Revolade;   Other: Placebo

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.